Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 14/20 | 0.53 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.40 |
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17326465 | 0.92 | APLNR (0.63) | APLNRNTSR1OPRM1OPRD1 | |
| SCHEMBL17326315 | 0.89 | APLNR (0.49) | APLNRNTSR1OPRM1OPRD1 | |
| SCHEMBL21468236 | 0.88 | APLNR (0.52) | APLNRNTSR1OPRM1OPRD1 | |
| SCHEMBL21229210 | 0.87 | APLNR (0.69) | APLNRNTSR1OPRM1OPRD1 | |
| SCHEMBL17326499 | 0.87 | APLNR (0.69) | APLNRNTSR1OPRM1OPRD1 | |
| SCHEMBL17326466 | 0.87 | APLNR (0.49) | APLNR | |
| SCHEMBL17930697 | 0.86 | APLNR (0.48) | APLNR | |
| SCHEMBL17929189 | 0.85 | APLNR (0.62) | APLNRNTSR1OPRM1OPRD1 | |
| SCHEMBL21249507 | 0.84 | APLNR (0.49) | APLNR | |
| SCHEMBL21249636 | 0.84 | APLNR (0.56) | APLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160207889-A1 | APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF | RESEARCH TRIANGLE INSTITUTE | 2016-07-21 | — | — | US | disclosed |
| US-20160207889-A1 | APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF | RESEARCH TRIANGLE INSTITUTE | 2016-07-21 | — | — | US | disclosed |
| WO-2015188073-A1 | APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF | RESEARCH TRIANGLE INSTITUTE (US) | 2015-12-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160207889-A1 | APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF | APLNR, AP1G1, APMAP | APLNR 1/4885NTSR1 15/4885OPRM1 172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.